Icon Plc (ICLR)
ICON provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. Co. provides a range of clinical, consulting and commercial services ranging from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. Co. focuses on development, management and analysis of programs that support clinical development process.
ICLR SEC Filing Email Alerts Service
Company Name: |
Icon Plc |
Stock buyback: |
ICLR buyback |
Website: |
www.iconplc.com |
Sector: |
Biotechnology |
Number of ETFs Holding ICLR: |
28 |
Total Market Value Held by ETFs: |
$412.34M |
Total Market Capitalization: |
$17.41B |
% of Market Cap. Held by ETFs: |
2.37% |
|
|
March 29, 2024 7:07 AM Eastern
Strong Buy (4.00 out of 4)
89th percentile
|
|